Senkyunolide A inhibits the progression of osteoarthritis by inhibiting the NLRP3 signalling pathway
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceutical Biology"
DOI: 10.1080/13880209.2022.2042327
Abstract: Abstract Context Osteoarthritis (OA) is a degenerative disease. Senkyunolide A (SenA) is an important phthalide from Ligusticum chuanxiong Hort (Umbelliferae) with anti-spasmodic and neuroprotective effects. Objective We explored the effect of SenA on IL-1β-stimulated chondrocytes… read more here.
Keywords: inhibits progression; progression; inhibiting nlrp3; nlrp3 signalling ... See more keywords